Skip to content
Screener

Mativ Holdings MATV FAM — Restructuring incurred to date

Similar metrics at other companies

Pfizer logo
PFEBiopharma — Restructuring cost incurred to date
$3.3B+22.2%
Campbell Soup logo
CPBCorporate — Restructuring and Related Cost, Cost Incurred to Date
$34M+183%
Campbell Soup logo
CPBSnacks — Restructuring and Related Cost, Cost Incurred to Date
$52M+420%
UL Solutions logo
ULSConsumer — Restructuring and Related Cost, Cost Incurred to Date
$27M
UL Solutions logo
ULSIndustrial — Restructuring and Related Cost, Cost Incurred to Date
$8M
Kennametal logo
KMTInfrastructure — Restructuring and related cost, cost incurred to date
$5.5M0.0%

Other financials

Income statement

See full
Revenue$531.8M+1.2%
Gross profit$113.3M+9.3%
Operating income$35.3M+75.6%
Net income$3.6M+138%
EPS (diluted)$0.06+133%

Balance sheet

See full
Cash & equivalents$70.8M-33.2%
Total debt$1.0B-10.9%
Total equity$470.7M+13.0%
Total assets$2.0B-4.1%

Cash flow

See full
Operating cash flow$67.9M+17.9%
CapEx$7.5M-13.8%
Free cash flow$60.4M+23.5%

Valuation

See full
Market cap$706.43M+37.3%
Enterprise value$1.67B+6.4%
P/S0.4×+0.1×

Profitability

See full
Gross margin19.4%+1.7pp
Operating margin2.9%+1.6pp
Net margin-22.1%
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity-68.5%
Debt / equity2.2×-0.6×
Current ratio-0.4×

Where this comes from

Reported directly by Mativ Holdings in its filing.

Tagged under the XBRL concept us-gaap:RestructuringAndRelatedCostCostIncurredToDate1.

The source filing: Mativ Holdings’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:35 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001000623-26-000067

(1) Includes costs associated with facility closures initiated in prior years of $0.6 million and $1.8 million for the three months ended June 30, 2026 and 2025, respectively. Through June 30, 2026, the Company has recognized accumulated restructuring and impairment charges of $12.7 million related to an ongoing facility closure. During the remainder of 2026, the Company expects to record additional restructuring costs in the FAM segment, not expected to exceed $1.5 million related to the closure of this facility.

Item 1. Financial Statements

FAQ

What is Mativ Holdings's FAM — restructuring incurred to date?
Mativ Holdings (MATV) reported FAM — restructuring incurred to date of $12.7M in Q2 2026.
How has Mativ Holdings's FAM — restructuring incurred to date changed year-over-year?
Mativ Holdings's FAM — restructuring incurred to date increased by 15.5% year-over-year, from $11M to $12.7M.
What does FAM — restructuring incurred to date mean?
The cumulative total of expenses recognized for restructuring initiatives within the FAM segment since the inception of a specific program. It provides visibility into the total capital committed to strategic transformation efforts over time.

Ask your AI about Mativ Holdings's fam — restructuring incurred to date.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude